Tyrosine-protein kinase JAK1 — Drug Target

All drugs that target Tyrosine-protein kinase JAK1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Janus Kinase Inhibitor [EPC]

Marketed (3)

• Cibinqo · Pfizer · Janus Kinase Inhibitor [EPC] · Immunology
  Cibinqo works by blocking the activity of the JAK1 enzyme, which plays a key role in the inflammatory response.
• Cibinqo · Pfizer · Janus Kinase Inhibitor [EPC] · Immunology
  Cibinqo works by blocking the JAK1 enzyme, which helps reduce inflammation in the body.
• Jyseleca · Gilead Sciences Ireland UC · Immunology